TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Popular Reads
No popular reads data found
Top Results
No results found. Please check your search term and try again
Can't find what you're looking for?
View all search results
Popular Reads
No popular reads data found
Top Results
No results found. Please check your search term and try again
Can't find what you're looking for?
View all search resultsHydroxychloroquine
World 5 years ago
US ends emergency authorization of hydroxychloroquine for COVID-19
The United States on Monday withdrew emergency use authorizations for two antimalarial drugs favored by President Donald Trump to treat the new coronavirus, effectively shutting the door on the politically charged treatments.
World 5 years ago
Does drug touted by Trump work on COVID-19? After data debacle, we still don't know
There is still a need for robust studies looking at whether it might work in low doses before or after exposure, as well as against mild cases, moderate cases, hospitalized patients and seriously ill ones.
World 5 years ago
Authors pull study flagging hydroxychloroquine risks
Three of the four authors behind a study in The Lancet that raised safety fears over the use of a drug favored by President Donald Trump to treat COVID-19 withdrew their research Thursday, blaming a company that supplied the data.
World 5 years ago
Trump still obese, but free of hydroxychloroquine side effects: White House
President Donald Trump did not suffer side effects from his controversial taking of hydroxychloroquine and is in good health, despite remaining obese, the White House said Wednesday, after he completed an annual medical check.
World 5 years ago
Study panning anti-malaria drug Trump took against COVID faces new questions
British medical journal the Lancet on Tuesday said it had concerns about data behind an influential article that found hydroxychloroquine increased the risk of death in COVID-19 patients, a conclusion that undercut scientific interest in the medicine championed by US President Donald Trump.
Health 5 years ago
Scientists raise concern over hydroxychloroquine study
Dozens of scientists have raised concerns over a large-scale study of hydroxychloroquine and chloroquine published in the Lancet that led to the World Health Organization suspending clinical trials of the anti-viral drugs as a potential treatment for COVID-19.
National 5 years ago
WHO trial suspends hydroxychloroquine treatment for new COVID-19 patients
According to a Health Ministry Research and Development Agency (Balitbangkes) letter addressed to the Indonesian Solidarity Trial research team, "hydroxychloroquine randomization for new subjects is suspended".
